RUNX1 and acute myeloid leukemia: Subsequently, Ro5-3335 has been used to inhibit RUNX1 during a variety of pathophysiological processes including, but not exclusively in, macrophages during septic shock,165 in retinal angiogenesis173 and, acute myeloid leukaemia.183